SAWAF AZIZ (SVP & CHIEF FINANCIAL OFFICER) reported 1 transaction at THERAVANCE BIOPHARMA, INC.
Review the transaction codes below to understand the nature of each event.
Filed: 2/24/2026ACC: 0001961289-26-000002
Officer· SVP & CHIEF FINANCIAL OFFICER
Since Feb 2026
-20.67K
Net shares
Net seller
$406.4K
Total sold
0
Open market trades
0B · 0S
1
Total transactions
20.67K disposed
Non-Derivative Transactions1
Ordinary Shares
Direct
Shares
−20.67K
Price / share
$19.66
Trade value
$406.41K
% of position
6.1%
2/20/2026
336.80K→316.12K
Total
Net shares
−20.67K
Net value
-$406.41K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Ordinary Shares Direct | 2/20/2026 | F · Tax Withholding | −20.67K | $19.66 | $406.41K | 6.1% | 336.80K | 316.12K |
| Total | −20.67K | -$406.41K | ||||||
Derivative Transactions0
No derivative transactions reported